Skip to main content
. 2020 Aug 3;28(7-8):839–849. doi: 10.1038/s41417-020-0206-7

Fig. 2. The association of GINS2, E-cad, and Vimentin with the survival of PC patients.

Fig. 2

a High (+) and low (−) expression of GINS2 against prognosis. b Normal (+) and abnormal (−) expression of E-cad against prognosis. c Positive (+) and negative (−) expression of Vimentin against prognosis. d Combination of GINS2 and E-cad against prognosis. e Combination of GINS2 and Vimentin against prognosis.